+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharmaceutical Analytical Testing Services in CRO Market Size, Share & Trends Analysis Report by Service (Bioanalytical Testing, Method Development & Validation), End-use, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 150 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 6098163
Description Jump to:
The Pharmaceutical Analytical Testing Services in CRO Market was valued at USD 7.52 billion in 2024, and is projected to reach USD 12.32 billion by 2030, rising at a CAGR of 8.61%. This growth is primarily attributed to factors such as the growing prevalence of chronic diseases, demand for outsourcing analytical testing services, investments in pharmaceutical R&D, and a shift toward cost-efficient drug development processes across the globe.

In addition, pharmaceuticals are increasingly outsourced to CROs to utilize specialized expertise, minimize their capital investment in the infrastructure, and streamline the timelines for the drug approval process and regulatory requirements. These tests are essential throughout development, from raw materials analysis and method validation to stability studies and impurity profiling.

As CROs offer advanced analytical technologies such as mass spectrometry, NGS, Raman spectroscopy, and automation/AI for rapid and accurate testing are expected to enhance the demand for pharmaceutical analytical testing services in CROs for developing personalized and precision medicine.

Moreover, factors such as an increasing pipeline of biologics, biosimilars, advanced therapies, and rising stringent quality control to enhance pharmaceutical products' safety, efficacy, and consistency are contributing to market growth. Besides, the expanding adoption of automation, artificial intelligence, and digital data management systems like Laboratory Information Management Systems (LIMS) in CROs is anticipated to boost the efficiency and reliability of analytical testing processes. This led pharmaceutical companies to expand their partnerships with CROs for cost-saving strategies and strategic collaborations that boost innovation, reduce risk, and improve time-to-market.

Furthermore, stringent regulatory frameworks worldwide are another major driver for the pharmaceutical analytical testing services in CRO market. Regulatory authorities such as the U.S. FDA, EMA, PMDA, and WHO require comprehensive analytical validation, method development, and stability testing to enhance drug safety, efficacy, and quality. These regulations are becoming increasingly stringent, particularly for complex biologics, biosimilars, and advanced therapies, mandating in-depth characterization and impurity profiling. The implementation of ICH guidelines (Q2, Q3, Q6) and GMP/GLP standards has intensified the demand for compliant analytical methodologies. Frequent audits and regulatory inspections further influence pharmaceutical companies to engage with specialized CROs possessing global regulatory knowledge, validated infrastructure, and quality management systems, allowing risk mitigation, faster approvals, and sustained market access across geographies.

Further, the adoption of Quality by Design (QbD) principles, which emphasize a systematic approach to product development, highlights the importance of early-stage analytical characterization. Under the QbD framework, pharmaceutical companies must define Critical Quality Attributes (CQAs) and ensure that variations in raw materials or manufacturing processes do not compromise product performance. The FDA's Process Analytical Technology (PAT) initiative promotes real-time monitoring of manufacturing parameters to maintain product consistency. This regulatory push, combined with the industry's transition toward more sophisticated drug formulations, is expanding the role of CROs in pharmaceutical analytical testing. Such aforementioned factors are expected to drive the overall market demand in the near future.

Global Pharmaceutical Analytical Testing Services In CRO Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the global pharmaceutical analytical testing services in CRO market report based on service, end use and region.

Service Outlook (Revenue, USD Million, 2018-2030)

  • Bioanalytical Testing
  • Clinical
  • Non-Clinical
  • Method Development & Validation
  • Extractable & Leachable
  • Impurity Method
  • Technical Consulting
  • Others
  • Stability Testing
  • Drug Substance
  • Stability Indicating Method Validation
  • Accelerated Stability Testing
  • Photostability Testing
  • Others
  • Others

End Use Outlook (Revenue, USD Million, 2018-2030)

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Others

Regional Outlook (Revenue, USD Million, 2018-2030)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
  • Poland
  • Switzerland
  • Austria
  • Czech Republic
  • Croatia
  • Slovenia
  • Greece
  • Asia-Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
  • Australia
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Argentina
  • UAE
  • Kuwait

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Pharmaceutical Analytical Testing Services in CRO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Pricing Model Analysis
3.4. Technology Landscape
3.5. Market Analysis Tools
3.5.1. Porter’s Five Force Analysis
3.5.2. PESTEL by SWOT Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Pharmaceutical Analytical Testing Services in CRO Market: Service Estimates & Trend Analysis
4.1. Pharmaceutical Analytical Testing Services in CRO Market, By Service: Segment Dashboard
4.2. Pharmaceutical Analytical Testing Services in CRO Market, By Service: Movement Analysis
4.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, By Service, 2018-2030 (USD Million)
4.4. Bioanalytical Testing
4.4.1. Bioanalytical Testing Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.2. Clinical
4.4.2.1. Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.3. Non-Clinical
4.4.3.1. Non-Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Method Development & Validation
4.5.1. Method Development & Validation Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.2. Extractable & Leachable
4.5.2.1. Extractable & Leachable Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.3. Impurity Method
4.5.3.1. Impurity Method Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.4. Technical Consulting
4.5.4.1. Technical Consulting Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.5. Others
4.5.5.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Stability Testing
4.6.1. Stability Testing Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6.2. Drug Substance
4.6.2.1. Drug Substance Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6.3. Stability Indicating Method Validation
4.6.3.1. Stability Indicating Method Validation Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6.4. Accelerated Stability Testing
4.6.4.1. Accelerated Stability Testing Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6.5. Photostability Testing
4.6.5.1. Photostability Testing Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6.6. Others
4.6.6.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.7. Others
4.7.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Pharmaceutical Analytical Testing Services in CRO Market: End Use Estimates & Trend Analysis
5.1. Pharmaceutical Analytical Testing Services in CRO Market, By End Use: Segment Dashboard
5.2. Pharmaceutical Analytical Testing Services in CRO Market, By End Use: Movement Analysis
5.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, By End Use, 2018-2030 (USD Million)
5.4. Pharmaceutical Companies
5.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Biopharmaceutical Companies
5.5.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Others
5.6.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Pharmaceutical Analytical Testing Services in CRO Market: Regional Estimates & Trend Analysis
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2024 & 2030
6.3. North America
6.3.1. North America Market Estimates and Forecasts, 2018-2030 (USD Million)
6.3.2. U.S
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. U.S. Market Estimates and Forecasts, 2018-2030 (USD Million)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Canada Market Estimates and Forecasts, 2018-2030 (USD Million)
6.3.4. Mexico
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. Mexico Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4. Europe
6.4.1. Europe Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. UK Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Germany Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. France Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Italy Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Spain Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. Sweden Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.8. Denmark
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Regulatory Framework
6.4.8.4. Denmark Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.9. Norway
6.4.9.1. Key Country Dynamics
6.4.9.2. Competitive Scenario
6.4.9.3. Regulatory Framework
6.4.9.4. Norway Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.10. Poland
6.4.10.1. Key Country Dynamics
6.4.10.2. Competitive Scenario
6.4.10.3. Regulatory Framework
6.4.10.4. Poland Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.11. Switzerland
6.4.11.1. Key Country Dynamics
6.4.11.2. Competitive Scenario
6.4.11.3. Regulatory Framework
6.4.11.4. Switzerland Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.12. Austria
6.4.12.1. Key Country Dynamics
6.4.12.2. Competitive Scenario
6.4.12.3. Regulatory Framework
6.4.12.4. Austria Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.13. Czech Republic
6.4.13.1. Key Country Dynamics
6.4.13.2. Competitive Scenario
6.4.13.3. Regulatory Framework
6.4.13.4. Czech Republic Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.14. Croatia
6.4.14.1. Key Country Dynamics
6.4.14.2. Competitive Scenario
6.4.14.3. Regulatory Framework
6.4.14.4. Croatia Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.15. Slovenia
6.4.15.1. Key Country Dynamics
6.4.15.2. Competitive Scenario
6.4.15.3. Regulatory Framework
6.4.15.4. Slovenia Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.16. Greece
6.4.16.1. Key Country Dynamics
6.4.16.2. Competitive Scenario
6.4.16.3. Regulatory Framework
6.4.16.4. Greece Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Japan Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. China Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. India Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.5. Thailand
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Thailand Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.6. South Korea
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. South Korea Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.7. Australia
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Australia Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Latin America
6.6.1. Latin America Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Brazil Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.3. Argentina
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Argentina Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7. MEA
6.7.1. MEA Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7.2. South Africa
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. South Africa Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7.4. UAE
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. UAE Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Kuwait Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Company Market Share/Assessment Analysis, 2024
7.3. Company Profiles
7.3.1. SGS Société Générale de Surveillance SA
7.3.1.1. Company Overview
7.3.1.2. Financial Performance
7.3.1.3. Service Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Worldwide Clinical Trials
7.3.2.1. Company Overview
7.3.2.2. Financial Performance
7.3.2.3. Service Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. Sofpromed
7.3.3.1. Company Overview
7.3.3.2. Financial Performance
7.3.3.3. Service Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. ClinChoice
7.3.4.1. Company Overview
7.3.4.2. Financial Performance
7.3.4.3. Service Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. Evotec
7.3.5.1. Company Overview
7.3.5.2. Financial Performance
7.3.5.3. Service Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. Eurofins Scientific
7.3.6.1. Company Overview
7.3.6.2. Financial Performance
7.3.6.3. Service Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. KYMOS Group
7.3.7.1. Company Overview
7.3.7.2. Financial Performance
7.3.7.3. Service Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. ViviaBiotech S.L.
7.3.8.1. Company Overview
7.3.8.2. Financial Performance
7.3.8.3. Service Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. GalChimia
7.3.9.1. Company Overview
7.3.9.2. Financial Performance
7.3.9.3. Service Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. TCI Laboratories
7.3.10.1. Company Overview
7.3.10.2. Financial Performance
7.3.10.3. Service Benchmarking
7.3.10.4. Strategic Initiatives
7.3.11. Cotecna (NEOTRON SpA,)
7.3.11.1. Company Overview
7.3.11.2. Financial Performance
7.3.11.3. Service Benchmarking
7.3.11.4. Strategic Initiatives
7.3.12. Tentamus
7.3.12.1. Company Overview
7.3.12.2. Financial Performance
7.3.12.3. Service Benchmarking
7.3.12.4. Strategic Initiatives
7.3.13. Enzymlogic
7.3.13.1. Company Overview
7.3.13.2. Financial Performance
7.3.13.3. Service Benchmarking
7.3.13.4. Strategic Initiatives
7.3.14. Pharmbiotest
7.3.14.1. Company Overview
7.3.14.2. Financial Performance
7.3.14.3. Service Benchmarking
7.3.14.4. Strategic Initiatives
7.3.15. UNIFARM - Research Centre
7.3.15.1. Company Overview
7.3.15.2. Financial Performance
7.3.15.3. Service Benchmarking
7.3.15.4. Strategic Initiatives
7.3.16. ANAPHARM EUROPE, S.L.U
7.3.16.1. Company Overview
7.3.16.2. Financial Performance
7.3.16.3. Service Benchmarking
7.3.16.4. Strategic Initiatives
List of Tables
Table 1 List of Tables
Table 2 List of Secondary Sources
Table 3 List of Abbreviations
Table 4 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 5 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 6 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Region, 2018-2030 (USD Million)
Table 7 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 8 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 9 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 10 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 11 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 12 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 13 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 14 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 15 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 16 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 17 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 18 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 19 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 20 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 21 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 22 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 23 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 24 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 25 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 26 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 27 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 28 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 29 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 30 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 31 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 32 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 33 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 34 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 35 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 36 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 37 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 38 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 39 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 40 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 41 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 42 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 43 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 44 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 45 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 46 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 47 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 48 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 49 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 50 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 51 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 52 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 53 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 54 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 55 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 56 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 57 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 58 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 59 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 60 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 61 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 62 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 63 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 64 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 65 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 66 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 67 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 68 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 69 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 70 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 71 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 72 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 73 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 74 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 75 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 76 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 77 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 78 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 79 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 80 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 81 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Commodity flow analysis
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD model sizing & forecasting
Figure 9 Bottom-up approach
Figure 10 Market snapshot
Figure 11 Segment snapshot 1
Figure 12 Segment snapshot 2
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook, 2024 (USD Billion)
Figure 15 Ancillary market outlook, 2024 (USD Billion)
Figure 16 Pharmaceutical Analytical Testing Services in CRO Market Dynamics
Figure 17 Porter’s five forces analysis
Figure 18 PESTEL analysis
Figure 19 Pharmaceutical Analytical Testing Services in CRO Market: Service outlook and key takeaways
Figure 20 Pharmaceutical Analytical Testing Services in CRO Market: Service movement analysis
Figure 21 Bioanalytical Testing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 22 Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 23 Non-Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 24 Method Development & Validation Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 25 Extractable & Leachable Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 26 Impurity Method Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 27 Technical Consulting Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 28 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 29 Stability Testing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 30 Drug Substance Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 31 Stability Indicating Method Validation Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 32 Accelerated Stability Testing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 33 Photostability Testing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 34 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 35 Others Service Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 36 Pharmaceutical Analytical Testing Services in CRO Market: End Use outlook and key takeaways
Figure 37 Pharmaceutical Analytical Testing Services in CRO Market: End Use movement analysis
Figure 38 Pharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 39 Biopharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 40 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 41 Regional Marketplace: Key Takeaways
Figure 42 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 43 Key Country Dynamics
Figure 44 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 45 Key Country Dynamics
Figure 46 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 47 Key Country Dynamics
Figure 48 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 49 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 50 Key Country Dynamics
Figure 51 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 52 Key Country Dynamics
Figure 53 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 54 Key Country Dynamics
Figure 55 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 56 Key Country Dynamics
Figure 57 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 58 Key Country Dynamics
Figure 59 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 60 Key Country Dynamics
Figure 61 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 62 Key Country Dynamics
Figure 63 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 64 Key Country Dynamics
Figure 65 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 66 Key Country Dynamics
Figure 67 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 68 Key Country Dynamics
Figure 69 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 70 Key Country Dynamics
Figure 71 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 72 Key Country Dynamics
Figure 73 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 74 Key Country Dynamics
Figure 75 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 76 Key Country Dynamics
Figure 77 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 78 Key Country Dynamics
Figure 79 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 80 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 81 Key Country Dynamics
Figure 82 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 83 Key Country Dynamics
Figure 84 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 85 Key Country Dynamics
Figure 86 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 87 Key Country Dynamics
Figure 88 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 89 Key Country Dynamics
Figure 90 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 91 Key Country Dynamics
Figure 92 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 93 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 94 Key Country Dynamics
Figure 95 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 96 Key Country Dynamics
Figure 97 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 98 MEA Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 99 Key Country Dynamics
Figure 100 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 101 Key Country Dynamics
Figure 102 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 103 Key Country Dynamics
Figure 104 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 105 Key Country Dynamics
Figure 106 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 107 Key company categorization
Figure 108 Service heat map analysis
Figure 109 Strategic framework

Companies Mentioned

The major companies featured in this Pharmaceutical Analytical Testing Services in CRO market report include:
  • SGS Société Générale de Surveillance SA
  • Worldwide Clinical Trials
  • Sofpromed
  • ClinChoice
  • Evotec
  • Eurofins Scientific
  • KYMOS Group
  • ViviaBiotech S.L.
  • GalChimia
  • TCI Laboratories
  • Cotecna (NEOTRON SpA,)
  • Tentamus
  • Enzymlogic
  • Pharmbiotest
  • UNIFARM - Research Centre
  • ANAPHARM EUROPE, S.L.U

Table Information

Report AttributeDetails
No. of Pages150
PublishedMay 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 7.52 Billion
Forecasted Market Value ( USD ) by 2030 $ 12.32 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Europe Pharmaceutical Analytical Testing Services In CRO Market Size, Share & Trends Analysis Report By Service (Bioanalytical Testing, Stability Testing, Method Development & Validation), By End-use (Pharmaceutical Companies), By Country, And Segment Forecasts, 2025 - 2030 - Product Image

Europe Pharmaceutical Analytical Testing Services In CRO Market Size, Share & Trends Analysis Report By Service (Bioanalytical Testing, Stability Testing, Method Development & Validation), By End-use (Pharmaceutical Companies), By Country, And Segment Forecasts, 2025 - 2030

  • Report
  • 90 Pages
  • Europe
From
Bioanalytical Testing Services in CRO Market Size, Share & Trends Analysis Report by Molecule (Small, Large), Test (Bioavailability, Bioequivalence), Test, Workflow, End-Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Bioanalytical Testing Services in CRO Market Size, Share & Trends Analysis Report by Molecule (Small, Large), Test (Bioavailability, Bioequivalence), Test, Workflow, End-Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 180 Pages
  • Global
From
U.S. Biopharmaceutical CMO & CRO Market Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars), And Segment Forecasts, 2023 - 2030 - Product Image

U.S. Biopharmaceutical CMO & CRO Market Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars), And Segment Forecasts, 2023 - 2030

  • Report
  • 122 Pages
  • United States
From
India Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing), By Model Type, By End-use (Biopharmaceutical Companies, Government & Academic Institutes), And Segment Forecasts, 2024 - 2030 - Product Image

India Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing), By Model Type, By End-use (Biopharmaceutical Companies, Government & Academic Institutes), And Segment Forecasts, 2024 - 2030

  • Report
  • 80 Pages
  • India
From
Biopharmaceutical CMO & CRO Market by Service Type, Product Type, Application, End User - Global Forecast to 2030 - Product Image

Biopharmaceutical CMO & CRO Market by Service Type, Product Type, Application, End User - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.